文献速递生殖医学妇科

从醋酸乌利司他到促性腺激素释放激素拮抗剂:壁间肌瘤相关不孕的激素治疗综述

Hormone therapy for intramural myoma-related infertility from ulipristal acetate to GnRH antagonist: a review.
PubMed 文献 · Reprod Biomed Online · 2020-06-09

本文综述壁间肌瘤相关不孕的机制及药物治疗,涉及选择性孕激素受体调节剂和促性腺激素释放激素拮抗剂,并提出基于机制的治疗流程。

要点

  • 壁间肌瘤通过宫腔扭曲、血供受损、收缩性增加及内膜容受性基因表达改变等机制影响不孕。
  • 壁间肌瘤的负面影响与肌瘤大小及与宫腔的邻近程度相关。
  • 药物治疗旨在缩小肌瘤并将其推回肌层深处,新治疗流程的建立迫在眉睫。

核心结论

  • 壁间肌瘤相关不孕的机制多样,药物治疗可作为缩小肌瘤并使其回退至肌层深部的策略,但围绕壁间肌瘤的谜团仍存,亟需开发新治疗流程并评估药物治疗作为一线方法的价值。

研究设计与样本

  • 综述,评估与壁间肌瘤相关的不孕,并回顾包括选择性孕激素受体调节剂和促性腺激素释放激素拮抗剂在内的相关药物治疗。

主要发现

  • 壁间肌瘤与不孕相关的机制包括:宫腔扭曲(肌瘤类型0、1、2、2-5)、子宫内膜和肌层血供受损、子宫收缩性增加、激素、旁分泌和分子改变、子宫内膜容受性基因表达受损(同源盒10[HOXA-10]表达下降)以及包膜增厚。
  • 壁间肌瘤的负面影响与肌瘤大小及与宫腔的邻近程度相关。
  • 药物治疗可被提议用于缩小肌瘤并将其推回肌层深处。

关键数值与推荐

  • 肌瘤根据国际妇产科联盟分类分为0、1、2、2-5型,宫腔扭曲与这些类型相关。
  • 子宫内膜容受性受损表现为HOXA-10表达下降。

临床怎么用

  • 作者提出一个考虑子宫肌瘤与不孕关联机制的治疗流程,并认为亟需评估药物治疗作为壁间肌瘤相关不孕一线方法的价值。

局限性

  • 围绕壁间肌瘤的谜团仍存。
  • 亟需开发壁间肌瘤相关不孕的新治疗流程并评估药物治疗作为一线方法的价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Uterine fibroids may cause infertility, depending on their size and location according to the International Federation of Gynecology and Obstetrics classification. In this review, infertility relating to intramural myomas is evaluated. The mechanisms linking uterine fibroids and infertility are numerous: uterine cavity distortion (fibroids types 0, 1, 2, 2-5); impaired endometrial and myometrial blood supply; increased uterine contractility; hormonal, paracrine and molecular changes; impaired endometrial receptivity in gene expression (decrease in homeobox 10 [HOXA-10] expression); and thicker capsule. The negative effect of intramural myoma is related to myoma size and proximity of the uterine cavity. Therefore, a medical approach could be proposed to reduce the size of the myoma and push it back deep into the myometrium. The relevant medical treatments, including selective progesterone receptor modulator and gonadotrophin releasing hormone antagonist are reviewed. Even if the mystery surrounding intramural myomas remains, the development of new algorithms for intramural myoma-related infertility, and evaluation of the place of medical treatment as a primary approach are urgently needed. An algorithm, taking into account the mechanisms linking uterine fibroids and infertility, is proposed.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Donnez J, Dolmans MM. Hormone therapy for intramural myoma-related infertility from ulipristal acetate to GnRH antagonist: a review. Reprod Biomed Online. 2020. PMID: 32703756. doi:10.1016/j.rbmo.2020.05.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。